As the FDA enforces the requirement for electronic data submission using SEND, pharmaceutical and biotech companies must adapt to this data-driven paradigm. PointCross Life Sciences emerges as a trusted partner, offering cloud-hosted or on-premises non-clinical solutions that streamline the process of becoming SEND ready. Embracing PointCross solutions empowers organizations to comply with regulatory mandates efficiently, optimize data management, and stay ahead of the curve in an increasingly data-centric industry. Contact PointCross today and embark on a seamless journey towards compliance with the FDA’s SEND mandate.
Related Posts
PhUSE EU Connect: Amsterdam
November 10 -13 | A live demo of our offerings or learning more about the release of our eDataValidator. read more
SEND ASSURE™ Whitepaper
Assuring your SEND Datasets are Consistent with your Study Report... read more
PHUSE US Connect 2025
Date: March 16-19, 2025Location: Orlando, Florida PointCross Life Sciences participated in PHUSE US Connect 2025 in Orlando, where Harinarayan Gopichandran... read more
Unified Machine Readable Target Data Models from Smart Transformer of Disparate Biopharma Source Data
Whitepaper - June 20, 2019 read more
